Endpoints News
Join us for Cell and Gene Day at 11 am E.T. Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Thu F
5 March, 2026
Drug Discovery Day 2026
AI-driven drug discovery is already reshaping pipelines. But algorithms alone won’t get a drug to the clinic. Join us for a free virtual program — then continue the conversation at an in-person only fireside chat and happy hour in Boston. Reserve your spot.
presented by TrialWire
The $50K-a-day prob­lem in clin­i­cal tri­al en­roll­ment
news
FDA puts PepGen’s Phase 2 muscle disease trial on partial hold
ENDPOINTS NEWS
Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’
ENDPOINTS NEWS
Updated: Sanofi licenses Sino Biopharm's 'breakout star' transplant drug for $135M upfront
ENDPOINTS NEWS
Endpoints webinars
Mar 24
11:30 am ET
From structure to selectivity: Federated AI for collaborative binding affinity prediction
Rhino Federated Computing
ONCOLOGY INDUSTRY PARTNERING EVENT FROM CANCER DISCOVERIES TO PATIENTS
Register to see thought-leaders across pharma and biotech present innovation strategies for drug development and new partnership and licensing opportunities to advance these concepts.
sponsored by American Association for Cancer Research
in case you missed it
1.
BIO chief maintains support for Makary, but calls some FDA decisions 'head-scratchers'
ENDPOINTS NEWS
2.
FDA's top operating official Butler to retire, deputy to take over in April
ENDPOINTS NEWS
3.
UCB boards T cell engager train in $60M upfront deal with Antengene
ENDPOINTS NEWS
4.
Blackstone to support Teva on Sanofi-partnered TL1A with $400M
ENDPOINTS NEWS
5.
News Briefing
Bayer continues trimming workforce; AnaptysBio's spinoff is named
ENDPOINTS NEWS
6.
Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds
THE NEW YORK TIMES
Reynald Castaneda
.

Endpoints’ Cell and Gene Day is happening later today. There's a virtual event featuring panels on China and the so-called plausible mechanism pathway, as well as a conversation with Bristol Myers' president of cell therapy Lynelle Hoch. Check out the agenda here, and we’ll see you then!

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times